Sucampo Pharma (Comparative Multiple Analysis)
Improve your investment analysis with by seeing the Sucampo Pharma's Discounted Cash Flow analysis, Sucampo Pharma's Warren Buffet analysis, and Sucampo Pharma's Weighted Average Cost of Capital (WACC) Analysis.
Notes on the Comparative Multiple Analysis of Sucampo Pharma
WikiWealth compares Sucampo Pharma's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Sucampo Pharma's comparative analysis.
Notes from the analysis:
1. WikiWealth uses quantitative measures to determine the multiple range for Sucampo Pharma.
Helpful Information for Sucampo Pharma's Analysis
How does this work? The Comparative Investment Analysis determines the value of Sucampo Pharma by comparing Sucampo Pharma financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.
Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Sucampo Pharma.
Also, see the Sucampo Pharma's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Sucampo Pharma's valuation conclusion for a quick summary.